5 completed, 2 recruiting. 4 Phase 3, 2 Phase 1, 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 3, Recruiting 1 |
| Phase 1 | 2 | Completed 2 |
| Not applicable | 1 | Recruiting 1 |
| Phase 2 | 1 | Completed 1 |
Follow Acute Urticaria: new trials by email Literature Review of Acute Urticaria trials Research Report on Acute Urticaria
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparing Standard-Dose and High-Dose Cetirizine for Acute Urticaria Cetirizine 10 mg once daily, Cetirizine 20 mg twice daily, total 40 mg/day - Acute Urticaria | Not applicable | Recruiting | University of Phayao | 140 | 2025-11-15 | 2026-10-05 |
| Phase III Clinical Study of Cetirizine Hydrochloride Injection in Treatment of Acute Urticaria Cetirizine Hydrochloride Injection, Diphenhydramine Hydrochloride Injection - Acute Urticaria | Phase 3 | Recruiting | Shandong New Time Pharmaceutical Co., LTD | 284 | 2024-04-22 | 2025-02-11 |
| Clinical Trial Comparing JDP-205 to Diphenhydramine Injection for the Treatment of Acute Urticaria Test Drug (JDP-205), Active Control (Diphenhydramine) - Acute Urticaria | Phase 3 | Completed | JDP Therapeutics, Inc. | 262 | 2017-03-01 | 2019-11-27 |
| Pilot Phase III Clinical Trial of JDP-205 IV Injection for Treatment of Acute Urticaria JDP-205 Injection, Diphenhydramine - Acute Urticaria | Phase 3 | Completed | JDP Therapeutics, Inc. | 36 | 2013-07-01 | 2024-02-09 |
| Glucocorticoids With Antihistamines Versus Antihistamines in Acute Urticaria in Emergency placebo, prednisone - Acute Urticaria | Phase 2 / Phase 3 | Completed | University Hospital, Toulouse | 100 | 2012-02-01 | 2023-05-23 |
| A Pilot Single Dose Crossover Pharmacokinetics Study Of JDP-205 Injection, 10 mg, In Healthy Male And Female Volunteers Deep muscle injection, Sub-Q Injection - Acute Urticaria | Phase 1 | Completed | JDP Therapeutics, Inc. | 4 | 2011-08-01 | 2024-03-06 |
| Safety, Tolerability and Pharmacokinetics Trial of JDP-205 Injection 10 mg JDP-205 IV high dose, JDP-205 IV low dose, JDP-205 IM - Acute Urticaria | Phase 1 | Completed | JDP Therapeutics, Inc. | 24 | 2011-03-01 | 2024-03-06 |
Exanthema (1) · Hypersensitivity (1) · Urticaria (1)
Skin Diseases (2) · Skin and Connective Tissue Diseases (2) · Hypersensitivity, Immediate (1) · Immune System Diseases (1) · Skin Diseases, Vascular (1)
Cetirizine (3) · Diphenhydramine (3) · Drug Evaluation (1) · Prednisone (1)
JDP Therapeutics, Inc. (4) · Shandong New Time Pharmaceutical Co., LTD (1) · University Hospital, Toulouse (1) · University of Phayao (1)
Canada (4) · United States (2) · China (1) · France (1) · Thailand (1)
Caroline Barniol, MD (1) · Janine North, B.S. (1) · Wasuchon Chaichan (1)
PMID 21810005, PMID 28476259, PMID 32653333, PMID 34536239, PMID 38280453, PMID 38420865, PMID 38642709